DMITRY OSTROVSKIY: Open Payments
NPI 1730462326 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 55 payments from 11 companies in 2025. Trend: 2023 $697 · 2024 $1,162 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 9 | $340 |
| ABBVIE INC. | 11 | $294 |
| Valinor Pharma, LLC | 9 | $184 |
| VERTEX PHARMACEUTICALS INCORPORATED | 6 | $158 |
| SCILEX PHARMACEUTICALS INC. | 7 | $132 |
| Lundbeck LLC | 3 | $72 |
| Forte Bio-Pharma LLC | 3 | $72 |
| Indivior Inc. | 3 | $65 |
| Biogen, Inc. | 2 | $51 |
| Mallinckrodt Hospital Products Inc. | 1 | $30 |
Products named: Leqembi, MOVANTIK, JOURNAVX, QULIPTA, ZTLido, UBRELVY, VYEPTI, PROLATE.
Industry payments across NY — which companies pay providers there.
